Percheron Therapeutics Ltd
F:AWY0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Percheron Therapeutics Ltd (AWY0) under the Base Case is EUR per share.
Compared with the current market price of 0.0005 EUR, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 11 months.
Create a free account · No card needed
Fundamental Analysis
What Percheron Therapeutics Does
Percheron Therapeutics Ltd is a AU-based company operating in Pharmaceuticals industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-12-20. Percheron Therapeutics Limited, formerly Antisense Therapeutics Limited, is a biotechnology company. The firm is engaged in developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The Company’s products include ATL1102 for Duchenne muscular dystrophy (DMD), ATL1103 for Acromegaly, and ATL1102 for Multiple Sclerosis (MS).
- Headquarters
- Australia AU
- IPO date
- Dec 20, 2001
Continue AWY0 Research
Decided on Percheron Therapeutics? Get an email when AWY0 reaches the price you’d buy at. Free with an account.
Other Percheron Therapeutics listings
What is the Intrinsic Value of one AWY0 stock?
The intrinsic value for
Percheron Therapeutics Ltd (AWY0) under the Base Case is EUR.
Is AWY0 stock undervalued or overvalued?
Compared with the current market price of 0.0005 EUR, the stock appears .